Our results show that miR-122 regulates cell proliferation through the PI3K/Akt/mTOR/p70S6K signaling pathway and exogenous overexpression of miR-122 may represent a promising approach for targeted BC therapies. The gene discussed is PIK3CG; the disease is breast cancer.